Impact of prophylactic cytomegalovirus immunoglobulin on cytomegalovirus viremia and graft function in ABO-incompatible living donor kidney transplantation: a retrospective analysis
CMV immunoglobulin represents a promising prophylactic option for reducing clinically relevant CMV viremia incidence and delaying infection onset in ABO-incompatible kidney transplant recipients.
Authors
- Yifu Hou
- Zhongshu Pu (ORCID: https://orcid.org/0000-0001-6087-6491)
- Shimei Tang (ORCID: https://orcid.org/0000-0003-1740-7838)
- Wenjia Di
- Linhong Zhong (ORCID: https://orcid.org/0009-0003-3037-6383)
- Hongji Yang (ORCID: https://orcid.org/0000-0001-6561-3631)
- Kai Chen (ORCID: https://orcid.org/0000-0002-7052-4681)
Institutions
- University of Electronic Science and Technology of China (CN)
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.3389/fimmu.2025.1562951
- Citations
- 3
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 4.06